These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30165444)

  • 1. Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism.
    Ohno Y; Sone M; Inagaki N; Yamasaki T; Ogawa O; Takeda Y; Kurihara I; Umakoshi H; Ichijo T; Katabami T; Wada N; Ogawa Y; Yoshimoto T; Kawashima J; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Miyauchi S; Kamemura K; Fukuoka T; Yamamoto K; Otsuki M; Suzuki T; Naruse M;
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4456-4464. PubMed ID: 30165444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex - a multicenter-study of 3566 Caucasian and Asian subjects.
    Spyroglou A; Handgriff L; Müller L; Schwarzlmüller P; Parasiliti-Caprino M; Fuss CT; Remde H; Hirsch A; O'Toole SM; Thuzar M; Petramala L; Letizia C; Deflorenne E; Amar L; Vrckovnik R; Kocjan T; Zhang CD; Li D; Singh S; Katabami T; Yoneda T; Murakami M; Wada N; Inagaki N; Quinkler M; Ghigo E; Maccario M; Stowasser M; Drake WM; Fassnacht M; Bancos I; Reincke M; Naruse M; Beuschlein F
    Eur J Endocrinol; 2022 Sep; 187(3):361-372. PubMed ID: 35895721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
    Somlóová Z; Widimský J; Rosa J; Wichterle D; Strauch B; Petrák O; Zelinka T; Vlková J; Masek M; Dvoráková J; Holaj R
    J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvascular endothelial function is impaired in patients with idiopathic hyperaldosteronism.
    Kishimoto S; Matsumoto T; Oki K; Maruhashi T; Kajikawa M; Matsui S; Hashimoto H; Kihara Y; Yusoff FM; Higashi Y
    Hypertens Res; 2018 Nov; 41(11):932-938. PubMed ID: 30206323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical Characteristics of Aldosterone Producing Adenoma and Idiopathic Hyperaldosteronism with Obstructive Sleep Apnea Hypopnea Syndrome].
    Zuo FJ; Zhou XH; Ren Y; Chen T; Tian HM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):298-303. PubMed ID: 32543133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased plasma prorenin levels in primary aldosteronism: potential diagnostic implications.
    Berge C; Courand PY; Harbaoui B; Paget V; Khettab F; Bricca G; Fauvel JP; Lantelme P
    J Hypertens; 2015 Jan; 33(1):118-25. PubMed ID: 25333683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aldosterone-producing adenoma on endothelial function and Rho-associated kinase activity in patients with primary aldosteronism.
    Matsumoto T; Oki K; Kajikawa M; Nakashima A; Maruhashi T; Iwamoto Y; Iwamoto A; Oda N; Hidaka T; Kihara Y; Kohno N; Chayama K; Goto C; Aibara Y; Noma K; Liao JK; Higashi Y
    Hypertension; 2015 Apr; 65(4):841-8. PubMed ID: 25624340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk factors for hepatic steatosis in patients with primary aldosteronism.
    Shibayama Y; Wada N; Baba S; Obara S; Sakai H; Usubuchi H; Terae S; Nakamura A; Atsumi T
    Endocr J; 2020 Jun; 67(6):623-629. PubMed ID: 32213734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Abdominal Computed Tomography Scans for Differentiating the Discrepancies in Abdominal Adipose Tissue Between Two Major Subtypes of Primary Aldosteronism.
    Chen KM; Lee BC; Chen PT; Liu KL; Lin KH; Chang CC; Wu TH; Hong JS; Lin YH
    Front Endocrinol (Lausanne); 2021; 12():647184. PubMed ID: 34335463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
    J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
    Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A
    Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Have main types of primary aldosteronism different phenotype?
    Somlóová Z; Indra T; Rosa J; Petrák O; Strauch B; Zelinka T; Holaj R; Widimský J
    Physiol Res; 2012; 61(4):431-6. PubMed ID: 22670702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocturnal, daytime, and postural changes of plasma aldosterone before and during dexamethasone in adenomatous and idiopathic aldosteronism.
    Hoefnagels WH; Drayer JI; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1330-4. PubMed ID: 7440698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between thyroid function, thyroid diseases, and primary aldosteronism.
    Maiturouzi M; Zhu Q; Zhang D; Luo Q; Wang M; Cai X; Heizhati M; Cai L; Wu T; Liu S; Dang Y; Aimudula A; Hong J; Li N
    Eur J Endocrinol; 2024 Aug; 191(2):262-270. PubMed ID: 39166829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma.
    Rossitto G; Regolisti G; Rossi E; Negro A; Nicoli D; Casali B; Toniato A; Caroccia B; Seccia TM; Walther T; Rossi GP
    Hypertension; 2013 Feb; 61(2):526-33. PubMed ID: 23248149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
    Rossi GP; Belfiore A; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Semplicini A; Agabiti-Rosei E; Pessina AC; Mantero F;
    J Hypertens; 2007 Jul; 25(7):1433-42. PubMed ID: 17563566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of midnight 1 mg dexamethasone suppression test combined with ACTH stimulation test in the diagnosis of primary aldosteronism subtypes].
    Qiu P; Zhang L; Jiang DY; Zang L; Guo QH; Lyu ZH; Mu YM
    Zhonghua Yi Xue Za Zhi; 2024 Jun; 104(24):2242-2248. PubMed ID: 38901981
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism.
    Mantero F; Fallo F; Opocher G; Armanini D; Boscaro M; Scaroni C
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():289s-293s. PubMed ID: 7032817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group).
    Kuo CC; Wu VC; Huang KH; Wang SM; Chang CC; Lu CC; Yang WS; Tsai CW; Lai CF; Lee TY; Lin WC; Wu MS; Lin YH; Chu TS; Lin CY; Chang HW; Wang WJ; Kao TW; Chueh SC; Wu KD; Taipai Study Group
    J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):348-57. PubMed ID: 21393359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.